|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
2 months to Mar 31, 2024
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Income from operations | |||||
| Accretion expense | |||||
| Gain on change in fair value of derivative liabilities | |||||
| Gain on termination of sales-type lease | |||||
| Interest expense | |||||
| Loss on settlement of legal proceedings | |||||
| Gain (loss) on disposal of assets | |||||
| Impairment loss | |||||
| Other income | |||||
| Net income from continuing operations before income tax expense | |||||
| Income tax expense | |||||
| Net loss from continuing operations after income tax expense | |||||
| Net loss from discontinued operations after income tax expense | |||||
| Net loss | |||||
| Other comprehensive income: | |||||
| Translation adjustment | |||||
| Comprehensive loss | |||||
| Basic loss per share from continuing operations | |||||
| Diluted loss per share from continuing operations | |||||
| Basic loss per share from discontinued operations | |||||
| Diluted loss per share from discontinued operations | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of common shares outstanding - basic | |||||
| Weighted average number of common shares outstanding - diluted |
Loading...